Yuanhuadine, a natural diterpene, enhances the degradation of AXL to overcome acquired gefitinib-resistance in lung cancer cells

被引：0
|
作者：
Bae, S. Y. [1 ]
Hong, J. Y. [1 ]
Lee, H. J. [1 ]
Park, H. J. [1 ]
Lee, S. K. [1 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
来源：
PLANTA MEDICA | 2015年 / 81卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
PH3
引用
收藏
页码：890 / 890
页数：1
相关论文
共 50 条
  • [1] Degradation of AXL overcome acquired cross-resistance to gefitinib and osimertinib in non-small cell lung cancer cells
    Kim, Donghwa
    Bach, Duc-Hiep
    Fan, Yan-hua
    Luu, Thi-Thu-Trang
    Hong, Ji-Young
    Park, Hyen-Joo
    Lee, Sang Kook
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Overcoming the Intrinsic Gefitinib-resistance via Downregulation of AXL in Non-small Cell Lung Cancer
    Jeong, Inae
    Song, Jayoung
    Bae, Song Yi
    Lee, Sang Kook
    JOURNAL OF CANCER PREVENTION, 2019, 24 (04) : 217 - 223
  • [3] MicroRNA expression profiles associated with acquired gefitinib-resistance in human lung adenocarcinoma cells
    Ge, Xiaojun
    Zheng, Limei
    Huang, Min
    Wang, Yonglun
    Bi, Feng
    MOLECULAR MEDICINE REPORTS, 2015, 11 (01) : 333 - 340
  • [4] Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer
    Bae, Song Yi
    Hong, Ji-Young
    Lee, Hye-Jung
    Park, Hyen Joo
    Lee, Sang Kook
    ONCOTARGET, 2015, 6 (12) : 10146 - 10160
  • [5] Vandetanib Can Overcome the Acquired Resistance to Gefitinib Due to RET Overexpression in Lung Cancer
    Sunohara, M.
    Kawakami, M.
    Watanabe, K.
    Morita, S.
    Kage, H.
    Amano, Y.
    Fukayama, M.
    Nagase, T.
    Ohishi, N.
    Takai, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 95 - 95
  • [6] AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells
    Donghwa Kim
    Duc-Hiep Bach
    Yan-Hua Fan
    Thi-Thu-Trang Luu
    Ji-Young Hong
    Hyen Joo Park
    Sang Kook Lee
    Cell Death & Disease, 10
  • [7] Overexpression and extended degradation rate of Axl in acquired gefitinib-resistant non-small cell lung cancer cells
    Kim, Donghwa
    Bach, Duc-Hiep
    Hong, Ji-Young
    Park, Hyen Joo
    Lee, Sang Kook
    CANCER RESEARCH, 2018, 78 (13)
  • [8] AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells
    Kim, Donghwa
    Bach, Duc-Hiep
    Fan, Yan-Hua
    Luu, Thi-Thu-Trang
    Hong, Ji-Young
    Park, Hyen Joo
    Lee, Sang Kook
    CELL DEATH & DISEASE, 2019, 10 (5)
  • [9] INHIBITORY EFFECTS OF MITOCHONDRIAL TRAP1 ON GEFITINIB-RESISTANCE IN NON-SMALL LUNG CANCER CELLS
    Kim, Hak-Ryul
    Oh, Su-Jin
    Jo, Jae-Sam
    Hwang, Ki-Eun
    Jeong, Eun-Taik
    RESPIROLOGY, 2017, 22 : 111 - 111
  • [10] Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells
    Liu, Zhongwei
    Gao, Weimin
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 335 : 16 - 27
12345